<code id='D3FCA1FFFF'></code><style id='D3FCA1FFFF'></style>
    • <acronym id='D3FCA1FFFF'></acronym>
      <center id='D3FCA1FFFF'><center id='D3FCA1FFFF'><tfoot id='D3FCA1FFFF'></tfoot></center><abbr id='D3FCA1FFFF'><dir id='D3FCA1FFFF'><tfoot id='D3FCA1FFFF'></tfoot><noframes id='D3FCA1FFFF'>

    • <optgroup id='D3FCA1FFFF'><strike id='D3FCA1FFFF'><sup id='D3FCA1FFFF'></sup></strike><code id='D3FCA1FFFF'></code></optgroup>
        1. <b id='D3FCA1FFFF'><label id='D3FCA1FFFF'><select id='D3FCA1FFFF'><dt id='D3FCA1FFFF'><span id='D3FCA1FFFF'></span></dt></select></label></b><u id='D3FCA1FFFF'></u>
          <i id='D3FCA1FFFF'><strike id='D3FCA1FFFF'><tt id='D3FCA1FFFF'><pre id='D3FCA1FFFF'></pre></tt></strike></i>

          leisure time

          leisure time

          author:fashion    Page View:693
          UnitedHealth Group
          UnitedHealth Group’s Optum will pay $3.3 billion total for the home health giant Amedisys. Jim Mone/AP

          Home health and hospice chain Amedisys has chosen a new corporate owner.

          Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

          advertisement

          Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          focus

          ChatGPT in medicine: STAT answers readers' burning questions
          ChatGPT in medicine: STAT answers readers' burning questions

          MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

          read more
          Editas, Vertex strike deal on CRISPR
          Editas, Vertex strike deal on CRISPR

          AdobeForadecade,leadingacademicinstitutesandtheirassociatedcompaniesfoughtabruising,headline-grabbin

          read more
          Medical records are filled with copy
          Medical records are filled with copy

          AdobeIrecentlytookcareofapatientwhosemedicalrecordsincludedmultiplenotesaboutherpastopen-heartsurger

          read more

          Orchard's therapy for neuron disease in children wins FDA approval

          AdobeTheFoodandDrugAdministrationonMondayapprovedagenetherapyformetachromaticleukodystrophy,adevasta